Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
134.6 USD | -1.64% | -6.67% | -3.22% |
Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
Apr. 09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Evolution of the average Target Price on Agilent Technologies, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Agilent Technologies, Inc.
Stifel Nicolaus | |
UBS | |
Barclays | |
BofA Securities | |
Goldman Sachs | |
Wells Fargo Securities | |
JPMorgan Chase | |
Nephron Research | |
TD Cowen | |
Bernstein | |
Jefferies & Co. | |
Baird | |
Evercore ISI | |
Credit Suisse | |
Morningstar | |
SVB Securities LLC | |
Citigroup | |
KeyBanc Capital Markets | |
Cowen | |
SVB Leerink | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- A Stock
- Consensus Agilent Technologies, Inc.